Pioglitazone and thyroid cancer risk in Taiwanese patients with type 2 diabetes
Journal
Journal of Diabetes
Journal Volume
6
Journal Issue
5
Pages
448-450
Date Issued
2014
Author(s)
SDGs
Other Subjects
acarbose; acetylsalicylic acid; angiotensin receptor antagonist; calcium channel blocking agent; clopidogrel; dipeptidyl carboxypeptidase inhibitor; dipyridamole; fibric acid derivative; hydroxymethylglutaryl coenzyme A reductase inhibitor; insulin; metformin; nonsteroid antiinflammatory agent; pioglitazone; rosiglitazone; sulfonylurea; ticlopidine; 2,4 thiazolidinedione derivative; antidiabetic agent; pioglitazone; adult; aged; article; cancer risk; comorbidity; dose response; female; human; insulin treatment; major clinical study; male; non insulin dependent diabetes mellitus; priority journal; Taiwan; thyroid cancer; treatment duration; Diabetes Mellitus, Type 2; insulin resistance; middle aged; protection; risk assessment; risk factor; Thyroid Neoplasms; time; treatment outcome; Adult; Aged; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Middle Aged; Protective Factors; Risk Assessment; Risk Factors; Taiwan; Thiazolidinediones; Thyroid Neoplasms; Time Factors; Treatment Outcome
Publisher
John Wiley and Sons Inc.
Type
journal article